Chronic Myeloid Leukemia Facts

 Story link:
 Saved by user, Anonymous on August 18, 2020; 05:01 PM
Chronic Myeloid Leukaemia (CML) is a cancer that develops when the blood forming cells of the bone marrow (the soft, spongy tissue in the center of bones) starts producing too many WBC (white blood cells), including immature ones. Managing patients with the CML in chronic phase has changed dramatically with the advent of the imatinib. The use of the Abl tyrosine kinase (TK) inhibitor, imatinib mesylate 400 mg (IM), for the treatment of patients with the chronic myeloid leukaemia (CML) in chronic phase appears to be well tolerated and effective

You May Also Read:

Randomly Post:
Know About Metal Braces Treatment?
Saved on June 06, 2019; 05:51 PM
Ios 10 Users Can Fix Two Maddening Issues Of Mail
Saved on April 28, 2017; 10:15 AM